The first non-surgical treatment option for a rare cancer subtype WASHINGTON — Mitomycin gel (Jelmyto), an alkylating drug, is now FDA-approved as the first non-surgical treatment for low-grade upper tract urothelial...
Read MoreAlgorithm helps identify which patients can be offered fertility-sparing treatment options Using the Proactive Molecular Classifier for endometrial cancer (ProMisE) algorithm to classify patients with endometrial cancer or...
Read MoreThe first non-surgical treatment option for a rare cancer subtype WASHINGTON — Mitomycin gel (Jelmyto), an alkylating drug, is now FDA-approved as the first non-surgical treatment for low-grade upper tract urothelial...
Read More
Ovarian cancer G protein-coupled receptor 1 (OGR1), also known as GPR68, is a proton-sensing G...
Read More
Female carriers of BRCA1 or BRCA2 germline mutations are at a substantially increased risk for...
Read More
Lipid-polymer hybrid nanoparticles (LPHNP) are suitable for co-delivery of hydrophilic and...
Read More
Amine/thiol-reactive chemistries are commonly used to conjugate antibodies to pharmaceuticals or...
Read More
Fungal periprosthetic joint infection (PJI) is a disruptive and complex complication of joint...
Read More
Human ovarian cancer specific transcript 2 (HOST2) is a long non-coding RNA (lncRNA) reported to...
Read More
Epithelial ovarian cancer (EOC) is one of the most common and lethal gynecological cancers. Novel...
Read More
Small nucleic acid (NA) therapeutics, such as small interfering RNA (siRNA), are generally...
Read More
Combination of chemotherapy and gene therapy provides an effective strategy for cancer treatment....
Read More
The overall risk of developing a second primary cancer is increasing. The purpose of this study...
Read More
The promoting effects of transcriptional factor Yin Yang 1 (YY1) have been confirmed in various...
Read More
Primary ovarian signet-ring cell carcinoma is extremely rare, with only five recent case reports....
Read More
The role of cancer stem cells (CSC) remains controversial and increasingly subject of...
Read More
Immune checkpoint blocking antibodies are currently being tested in ovarian cancer (OC) patients...
Read More
IRE1α endonuclease is a key regulator of endoplasmic reticulum (ER) stress that controls cell...
Read More
Changes in energy metabolism may be potential biomarkers and therapeutic targets for cancer as...
Read More
Treatment for ovarian cancer has been challenging for many years. It is composed of debulking...
Read More